[Fungal infections in oncohematology: the role of prophylaxis]

Related Experiment Video

Updated: Jun 12, 2026

An Ex vivo Assay to Study Candida albicans Hyphal Morphogenesis in the Gastrointestinal Tract
07:42

An Ex vivo Assay to Study Candida albicans Hyphal Morphogenesis in the Gastrointestinal Tract

Published on: July 1, 2020

P Sobrevilla Calvo1

  • 1Instituto Nacional de Cancerologia, Mexico, D.F.

Drugs of Today (Barcelona, Spain : 1998)
|May 22, 2010
PubMed

Insights

Fungal infections are evolving in oncohematology patients due to new risk factors and treatments. Management strategies include prophylaxis, empirical, preemptive, and specific therapies for high-risk patients.

Area of Science:

  • Oncology
  • Infectious Diseases
  • Hematology

Context:

  • Fungal infections in oncohematology patients are increasingly complex.
  • Factors include better bacterial infection control, antifungal prophylaxis, and emerging pathogens.
  • Immunosuppressive therapies (dexamethasone, fludarabine, rituximab) and graft-versus-host disease (GVHD) increase risk.

Purpose:

  • To highlight the changing landscape of fungal infections in patients with oncohematological diseases.
  • To identify high-risk clinical scenarios and patient populations.
  • To outline current management approaches for invasive fungal infections.

Summary:

  • The incidence and spectrum of fungal infections are shifting in oncohematology.
  • High-risk scenarios include acute leukemia, hematopoietic transplant, GVHD, and treatments with purine analogs or alemtuzumab.
  • Management involves a multi-faceted approach: prophylaxis, empirical, preemptive, and specific treatments.

Impact:

  • Improved understanding of evolving fungal infection risks in immunocompromised patients.
  • Guidance for clinicians in managing complex fungal infections in oncohematology.
  • Potential for optimized treatment strategies to reduce morbidity and mortality.

More Related Videos

Bone Marrow Transplantation Platform to Investigate the Role of Dendritic Cells in Graft-versus-Host Disease08:05

Bone Marrow Transplantation Platform to Investigate the Role of Dendritic Cells in Graft-versus-Host Disease

Published on: March 17, 2020

Related Concept Videos

Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Antifungal Agents01:15

Antifungal Agents

Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...
Candidiasis01:20

Candidiasis

Candidiasis is a fungal infection caused by opportunistic species of Candida. It can affect various anatomical sites, including the skin, oral cavity, nails, and genitourinary tract. Among its forms, vaginal candidiasis is the most common type of mucosal infection. It typically results from the overgrowth of Candida albicans in the vaginal mucosa. Under normal conditions, C. albicans exists as a commensal organism within the vaginal microbiota, regulated by the dominance of lactobacilli, which...
Fungal Phylum Microsporidia01:28

Fungal Phylum Microsporidia

Microsporidia are a group of obligate intracellular fungi that were initially classified as protists but were later reclassified based on phylogenetic, molecular, and structural evidence linking them to the Chytridiomycota. These unicellular, non-motile organisms are highly specialized parasites that infect a wide range of animal hosts, including humans. They have evolved extensive genomic and metabolic reductions, making them highly dependent on their hosts for survival.Morphology and Genomic...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...